APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Engineering Technology Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cell Engineering Technology Platform Market Outlook and Growth Opportunities 2026

1 January 2026196 pages

Choose your research edition.

Industry ResearchCell Engineering Technology Platform Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Engineering Technology Platform Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Cell Engineering Technology Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Engineering Technology Platform Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Engineering Technology Platform Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Cell Engineering Technology Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cell Engineering Technology Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cell Engineering Technology Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell Engineering Technology Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cell Engineering Technology Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cell Engineering Technology Platform market include Portal Biotechnologies, Lonza Group, Thermo Fisher Scientific, Sartorius, GenScript, Metagenomi, CorrectSequence Therapeutics and Eddie Gene, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cell Engineering Technology Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell Engineering Technology Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell Engineering Technology Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cell Engineering Technology Platform market.

Cell Engineering Technology Platform Segment by Company

Portal Biotechnologies

Lonza Group

Thermo Fisher Scientific

Sartorius

GenScript

Metagenomi

CorrectSequence Therapeutics

Eddie Gene

Cell Engineering Technology Platform Segment by Type

Gene Editing

Cell Line Development

Others

Cell Engineering Technology Platform Segment by Application

Medical Industry

Scientific Research

Others

Cell Engineering Technology Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cell Engineering Technology Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cell Engineering Technology Platform key companies, revenue, market share, and recent developments.

3. To split the Cell Engineering Technology Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cell Engineering Technology Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cell Engineering Technology Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Cell Engineering Technology Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Engineering Technology Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Engineering Technology Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Engineering Technology Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Engineering Technology Platform industry.

Chapter 3: Detailed analysis of Cell Engineering Technology Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cell Engineering Technology Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cell Engineering Technology Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cell Engineering Technology Platform Industry Trends Table 2. Cell Engineering Technology Platform Industry Drivers Table 3. Cell Engineering Technology Platform Industry Opportunities and Challenges Table 4. Cell Engineering Technology Platform Industry Restraints Table 5. Global Cell Engineering Technology Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cell Engineering Technology Platform Revenue Share by Company (2021-2026) Table 7. Global Cell Engineering Technology Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cell Engineering Technology Platform Key Company Manufacturing Base & Headquarters Table 9. Global Cell Engineering Technology Platform Company, Product Type & Application Table 10. Global Cell Engineering Technology Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cell Engineering Technology Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Gene Editing Table 15. Significant Companies of Cell Line Development Table 16. Significant Companies of Others Table 17. Global Cell Engineering Technology Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Cell Engineering Technology Platform Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Cell Engineering Technology Platform Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Cell Engineering Technology Platform Sales Value Share by Type (2021-2026) Table 21. Global Cell Engineering Technology Platform Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Medical Industry Table 23. Significant Companies of Scientific Research Table 24. Significant Companies of Others Table 25. Global Cell Engineering Technology Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cell Engineering Technology Platform Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Cell Engineering Technology Platform Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Cell Engineering Technology Platform Sales Value Share by Application (2021-2026) Table 29. Global Cell Engineering Technology Platform Sales Value Share by Application (2027-2032) Table 30. Global Cell Engineering Technology Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cell Engineering Technology Platform Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Cell Engineering Technology Platform Sales Value Share by Region (2021-2026) Table 33. Global Cell Engineering Technology Platform Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Cell Engineering Technology Platform Sales Value Share by Region (2027-2032) Table 35. Global Cell Engineering Technology Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Cell Engineering Technology Platform Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Cell Engineering Technology Platform Sales Value Market Share by Country (2021-2026) Table 38. Global Cell Engineering Technology Platform Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Cell Engineering Technology Platform Sales Value Market Share by Country (2027-2032) Table 40. Portal Biotechnologies Company Information Table 41. Portal Biotechnologies Business Overview Table 42. Portal Biotechnologies Cell Engineering Technology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Portal Biotechnologies Cell Engineering Technology Platform Product Portfolio Table 44. Portal Biotechnologies Recent Development Table 45. Lonza Group Company Information Table 46. Lonza Group Business Overview Table 47. Lonza Group Cell Engineering Technology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Lonza Group Cell Engineering Technology Platform Product Portfolio Table 49. Lonza Group Recent Development Table 50. Thermo Fisher Scientific Company Information Table 51. Thermo Fisher Scientific Business Overview Table 52. Thermo Fisher Scientific Cell Engineering Technology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Thermo Fisher Scientific Cell Engineering Technology Platform Product Portfolio Table 54. Thermo Fisher Scientific Recent Development Table 55. Sartorius Company Information Table 56. Sartorius Business Overview Table 57. Sartorius Cell Engineering Technology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Sartorius Cell Engineering Technology Platform Product Portfolio Table 59. Sartorius Recent Development Table 60. GenScript Company Information Table 61. GenScript Business Overview Table 62. GenScript Cell Engineering Technology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. GenScript Cell Engineering Technology Platform Product Portfolio Table 64. GenScript Recent Development Table 65. Metagenomi Company Information Table 66. Metagenomi Business Overview Table 67. Metagenomi Cell Engineering Technology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Metagenomi Cell Engineering Technology Platform Product Portfolio Table 69. Metagenomi Recent Development Table 70. CorrectSequence Therapeutics Company Information Table 71. CorrectSequence Therapeutics Business Overview Table 72. CorrectSequence Therapeutics Cell Engineering Technology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. CorrectSequence Therapeutics Cell Engineering Technology Platform Product Portfolio Table 74. CorrectSequence Therapeutics Recent Development Table 75. Eddie Gene Company Information Table 76. Eddie Gene Business Overview Table 77. Eddie Gene Cell Engineering Technology Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Eddie Gene Cell Engineering Technology Platform Product Portfolio Table 79. Eddie Gene Recent Development Table 80. Research Programs/Design for This Report Table 81. Authors List of This Report Table 82. Secondary Sources Table 83. Primary Sources List of Figures Figure 1. Cell Engineering Technology Platform Product Image Figure 2. Global Cell Engineering Technology Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell Engineering Technology Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Cell Engineering Technology Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Gene Editing Image Figure 8. Cell Line Development Image Figure 9. Others Image Figure 10. Global Cell Engineering Technology Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Cell Engineering Technology Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Cell Engineering Technology Platform Sales Value Share by Type (2021-2032) Figure 13. Medical Industry Image Figure 14. Scientific Research Image Figure 15. Others Image Figure 16. Global Cell Engineering Technology Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cell Engineering Technology Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Cell Engineering Technology Platform Sales Value Share by Application (2021-2032) Figure 19. Global Cell Engineering Technology Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Cell Engineering Technology Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Cell Engineering Technology Platform Sales Value (2021-2032) & (US$ Million) Figure 22. North America Cell Engineering Technology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Cell Engineering Technology Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Cell Engineering Technology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Cell Engineering Technology Platform Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Cell Engineering Technology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Cell Engineering Technology Platform Sales Value (2021-2032) & (US$ Million) Figure 28. South America Cell Engineering Technology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Cell Engineering Technology Platform Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Cell Engineering Technology Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Editing
  • Cell Line Development
  • Others
Applications
  • Medical Industry
  • Scientific Research
  • Others
Companies covered
  • Portal Biotechnologies
  • Lonza Group
  • Thermo Fisher Scientific
  • Sartorius
  • GenScript
  • Metagenomi
  • CorrectSequence Therapeutics
  • Eddie Gene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cell Engineering Technology Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cell Engineering Technology Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cell Engineering Technology Platform Market Dynamics
  1. 2.1 Cell Engineering Technology Platform Industry Trends
  2. 2.2 Cell Engineering Technology Platform Industry Drivers
  3. 2.3 Cell Engineering Technology Platform Industry Opportunities and Challenges
  4. 2.4 Cell Engineering Technology Platform Industry Restraints
3 Cell Engineering Technology Platform Market by Company
  1. 3.1 Global Cell Engineering Technology Platform Company Revenue Ranking in 2025
  2. 3.2 Global Cell Engineering Technology Platform Revenue by Company (2021-2026)
  3. 3.3 Global Cell Engineering Technology Platform Company Ranking (2024-2026)
  4. 3.4 Global Cell Engineering Technology Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Cell Engineering Technology Platform Company Product Type and Application
  6. 3.6 Global Cell Engineering Technology Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cell Engineering Technology Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cell Engineering Technology Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cell Engineering Technology Platform Market by Type
  1. 4.1 Cell Engineering Technology Platform Type Introduction
  2. 4.1.1 Gene Editing
  3. 4.1.2 Cell Line Development
  4. 4.1.3 Others
  5. 4.2 Global Cell Engineering Technology Platform Sales Value by Type
  6. 4.2.1 Global Cell Engineering Technology Platform Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Cell Engineering Technology Platform Sales Value by Type (2021-2032)
  8. 4.2.3 Global Cell Engineering Technology Platform Sales Value Share by Type (2021-2032)
5 Cell Engineering Technology Platform Market by Application
  1. 5.1 Cell Engineering Technology Platform Application Introduction
  2. 5.1.1 Medical Industry
  3. 5.1.2 Scientific Research
  4. 5.1.3 Others
  5. 5.2 Global Cell Engineering Technology Platform Sales Value by Application
  6. 5.2.1 Global Cell Engineering Technology Platform Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cell Engineering Technology Platform Sales Value by Application (2021-2032)
  8. 5.2.3 Global Cell Engineering Technology Platform Sales Value Share by Application (2021-2032)
6 Cell Engineering Technology Platform Regional Value Analysis
  1. 6.1 Global Cell Engineering Technology Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cell Engineering Technology Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cell Engineering Technology Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cell Engineering Technology Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cell Engineering Technology Platform Sales Value (2021-2032)
  7. 6.3.2 North America Cell Engineering Technology Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cell Engineering Technology Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Cell Engineering Technology Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cell Engineering Technology Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cell Engineering Technology Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cell Engineering Technology Platform Sales Value (2021-2032)
  16. 6.6.2 South America Cell Engineering Technology Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cell Engineering Technology Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cell Engineering Technology Platform Sales Value Share by Country, 2025 VS 2032
7 Cell Engineering Technology Platform Country-level Value Analysis
  1. 7.1 Global Cell Engineering Technology Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cell Engineering Technology Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cell Engineering Technology Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cell Engineering Technology Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cell Engineering Technology Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cell Engineering Technology Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cell Engineering Technology Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Portal Biotechnologies
  2. 8.1.1 Portal Biotechnologies Company Information
  3. 8.1.2 Portal Biotechnologies Business Overview
  4. 8.1.3 Portal Biotechnologies Cell Engineering Technology Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Portal Biotechnologies Cell Engineering Technology Platform Product Portfolio
  6. 8.1.5 Portal Biotechnologies Recent Developments
  7. 8.2 Lonza Group
  8. 8.2.1 Lonza Group Company Information
  9. 8.2.2 Lonza Group Business Overview
  10. 8.2.3 Lonza Group Cell Engineering Technology Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lonza Group Cell Engineering Technology Platform Product Portfolio
  12. 8.2.5 Lonza Group Recent Developments
  13. 8.3 Thermo Fisher Scientific
  14. 8.3.1 Thermo Fisher Scientific Company Information
  15. 8.3.2 Thermo Fisher Scientific Business Overview
  16. 8.3.3 Thermo Fisher Scientific Cell Engineering Technology Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thermo Fisher Scientific Cell Engineering Technology Platform Product Portfolio
  18. 8.3.5 Thermo Fisher Scientific Recent Developments
  19. 8.4 Sartorius
  20. 8.4.1 Sartorius Company Information
  21. 8.4.2 Sartorius Business Overview
  22. 8.4.3 Sartorius Cell Engineering Technology Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sartorius Cell Engineering Technology Platform Product Portfolio
  24. 8.4.5 Sartorius Recent Developments
  25. 8.5 GenScript
  26. 8.5.1 GenScript Company Information
  27. 8.5.2 GenScript Business Overview
  28. 8.5.3 GenScript Cell Engineering Technology Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GenScript Cell Engineering Technology Platform Product Portfolio
  30. 8.5.5 GenScript Recent Developments
  31. 8.6 Metagenomi
  32. 8.6.1 Metagenomi Company Information
  33. 8.6.2 Metagenomi Business Overview
  34. 8.6.3 Metagenomi Cell Engineering Technology Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Metagenomi Cell Engineering Technology Platform Product Portfolio
  36. 8.6.5 Metagenomi Recent Developments
  37. 8.7 CorrectSequence Therapeutics
  38. 8.7.1 CorrectSequence Therapeutics Company Information
  39. 8.7.2 CorrectSequence Therapeutics Business Overview
  40. 8.7.3 CorrectSequence Therapeutics Cell Engineering Technology Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CorrectSequence Therapeutics Cell Engineering Technology Platform Product Portfolio
  42. 8.7.5 CorrectSequence Therapeutics Recent Developments
  43. 8.8 Eddie Gene
  44. 8.8.1 Eddie Gene Company Information
  45. 8.8.2 Eddie Gene Business Overview
  46. 8.8.3 Eddie Gene Cell Engineering Technology Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eddie Gene Cell Engineering Technology Platform Product Portfolio
  48. 8.8.5 Eddie Gene Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst